CCOC(=O)CCC1(C(=O)O[C@@H]2C[C@H](C)CC[C@H]2C(C)C)CCCCC1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?